Financial Statements — CNXU
Balance Sheet
(in millions USD)| Metric | Q3
2026 | Q2
2026 |
|---|
| Cash & Equivalents | 1.97 | 6.85 |
| Total Current Assets | 6.76 | 7.91 |
| Property, Plant & Equipment | 0.07 | 0.04 |
| Intangible Assets | 0.16 | 0.16 |
| Total Non-current Assets* | 0.40 | 0.29 |
| Total Assets | 7.16 | 8.20 |
| Accounts Payable | 0.78 | 0.46 |
| Total Current Liabilities | 1.27 | -- |
| Total Non-current Liabilities* | 0.03 | -- |
| Total Liabilities | 1.31 | 1.00 |
| Retained Earnings | (16.27) | (8.54) |
| Total Stockholder Equity | 5.85 | 7.20 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q3
2026 | Q2
2026 |
|---|
| Research & Development | 0.27 | 0.07 |
| Selling, General & Admin | 0.03 | 0.02 |
| Total Operating Expenses | 7.69 | 2.38 |
| Operating Income | (7.69) | (2.38) |
| Interest Expense | 0.00 | 0.00 |
| Pretax Income | (7.73) | (2.30) |
| Tax Provision | 0.00 | 0.00 |
| Net Income | (7.73) | (2.30) |
| Basic EPS | (0.29) | (0.11) |
| Diluted EPS | (0.29) | (0.11) |
Cash Flow Statement
(in millions USD)| Metric | Q3
2026 | Q2
2026 |
|---|
| Operating Cash Flow | (6.76) | (3.34) |
| Capital Expenditures | 0.04 | 0.03 |
| Free Cash Flow* | (6.80) | (3.38) |
| Investing Cash Flow | (0.04) | (0.03) |
| Financing Cash Flow | 1.37 | 5.84 |
* Derived from reported values
